Royal Bank of Canada Raises IDEAYA Biosciences (NASDAQ:IDYA) Price Target to $53.00

IDEAYA Biosciences (NASDAQ:IDYA – Get Free Report) had its target price lifted by research analysts at Royal Bank of Canada from $43.00 to $53.00 in a report released on Wednesday, Benzinga reports. The brokerage currently has an “outperform” rating on the stock. Royal Bank of Canada’s price target would indicate a potential upside of 19.42% […]

Related Keywords

Canada ,Blackrock ,Nova Scotia ,Yujiros Hata ,Briseno Andres Ruiz ,Goldman Sachs Group ,Blackrock Inc ,Royal Bank ,Securities Exchange Commission ,Biosciences Inc ,Capital Research Global Investors ,Jpmorgan Chase Co ,Pricet Rowe Associates Inc ,Get Free Report ,Exchange Commission ,Research Global Investors ,Pricet Rowe Associates ,Ideaya Biosciences ,Nasdaq Idya ,Nidya ,Medical ,Boost Price Target ,Royal Bank Of Canada ,